Humedix Obtains GMP Certification for Biopharmaceutical Product Manufacturing Line

[NA Eun-kyung, Edaily Reporter] Humedix is accelerating its expansion into the global biopharmaceutical contract manufacturing organization (CMO) market by strengthening its biopharmaceutical manufacturing capabilities.

Humedix (CEO Kang Min-jong), a subsidiary of Huons Group, announced on August 3 that it has received Good Manufacturing Practice (GMP) certification from South Korea’s Ministry of Food and Drug Safety (MFDS) for biopharmaceutical contract manufacturing operations.

The GMP certification covers the company’s drug product manufacturing facility for recombinant biopharmaceuticals.